It is a chemicals private limited company based in Thane, Maharashtra, India, established in 2014.
2014 | Thane, Maharashtra, India | Struck OffMediclave Pharmaceuticals Private Limited, a struck off private limited company, was established on 09 July 2014 in Thane, Maharashtra, India. Engaging in medicinal chemical & botanical products within the chemicals sector, it holds CIN: U24233MH2014PTC255944. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Ketan Jayant Desai (Director), Satyen Pratap Shah (Director). Past directors included Jigna Dhanraj Mehta, Ojasbhai Vasantbhai Khokhani. Its latest AGM occurred on 21 August 2019, with the balance sheet filed on 31 March 2019. It is based at Flat No. 11, Wing 22B, Brindavan Vaibhav N.G Marg, Brindaban, Thane, Maharashtra, 400601.
U24233MH2014PTC255944
255944
09 July 2014
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Mediclave Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ketan Jayant Desai | Director | 09 Jul 2014 | Current |
| Satyen Pratap Shah | Director | 09 Jul 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 27 Jun 2018 | Past |
| Pramod Abcsdd | Director | 21 Nov 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mediclave Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Mediclave Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Mediclave Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mediclave Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediclave Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mediclave Pharmaceuticals Private Limited last Annual general meeting of members was held on 21 Aug 2019 as per latest MCA records. was recorded as a recent event.
The activity Mediclave Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Mumbai. was completed.
Progress on Ketan Jayant Desai was appointed as a Director was appointed as a Director on 09 Jul 2014 & has been associated with this company since 11 years 5 months . was documented.
Progress on Satyen Pratap Shah was appointed as a Director was appointed as a Director on 09 Jul 2014 & has been associated with this company since 11 years 5 months . was documented.
The activity Mediclave Pharmaceuticals Private Limited was registered on 09 Jul 2014 with Roc Mumbai & aged 11 years 5 months as per MCA records. was completed.
The CIN of Mediclave Pharmaceuticals Private Limited is U24233MH2014PTC255944.
Mediclave Pharmaceuticals Private Limited is headquartered at Flat No. 11, Wing 22B, Brindavan Vaibhav N.G Marg, Brindaban, Thane, Maharashtra, 400601.
Mediclave Pharmaceuticals Private Limited was incorporated on 09 July 2014.
The current directors of Mediclave Pharmaceuticals Private Limited are
The primary industry of Mediclave Pharmaceuticals Private Limited is Chemicals.
Mediclave Pharmaceuticals Private Limited is unlisted.
The authorized capital of Mediclave Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Mediclave Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX